| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-73-6-929 |
| P698 | PubMed publication ID | 4947941 |
| P50 | author | Jerome Lowenstein | Q48081448 |
| P2093 | author name string | R T McCluskey | |
| G Gallo | |||
| N F Rothfield | |||
| D S Baldwin | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 929-942 | |
| P577 | publication date | 1970-12-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | The clinical course of the proliferative and membranous forms of lupus nephritis | |
| P478 | volume | 73 |
| Q44482867 | A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis |
| Q41151725 | A review of glomerular ultrastructure in systemic lupus erythematosus |
| Q68787306 | Acute renal failure in systemic lupus erythematosus |
| Q67510775 | Antibodies reacting with the glomerular mesangium. Isolation and immunopathology |
| Q33603359 | Aortic regurgitation in systemic lupus erythematosus requiring aortic valve replacement |
| Q41116186 | Arthritis and hypertension in patients with systemic lupus erythematosus |
| Q42728808 | Atypical presentation and clinical course in mesangial lupus nephritis |
| Q39362656 | Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis |
| Q44681538 | C-reactive protein in systemic lupus erythematosus |
| Q54495737 | Chlorambucil in the treatment of systemic lupus erythematosus |
| Q39780955 | Clinical assessment of immune-complex disease in children with systemic lupus erythematosus |
| Q69494938 | Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis |
| Q43975902 | Clinical significance of immune deposits in the skin in SLE |
| Q35196683 | Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus |
| Q70057436 | Clinical use of corticosteroids in renal disease |
| Q40908779 | Clinico-pathological diagnostic problems: fever, arthralgia and renal disease in a young woman |
| Q93716479 | Clinicopathological correlations of primary haematuria |
| Q36052749 | Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study. |
| Q39536979 | Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis |
| Q71821906 | Connective tissue diseases |
| Q36101807 | Contributions of renal biopsy studies to the understanding of disease |
| Q69552546 | Correlation of renal histology with outcome in children with lupus nephritis |
| Q44693450 | Current concepts in management of lupus nephritis |
| Q37949332 | Current treatment recommendations for lupus nephritis |
| Q33906791 | Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature |
| Q41913465 | David S. Baldwin, MD: a legacy in nephrology |
| Q43604133 | Detection of DNA-bound immunoglobulins in patients with lupus nephritis, using monoclonal anti-DNA antibody |
| Q40087709 | Diagnosis and Treatment of Hypertension in Children |
| Q70624757 | Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome |
| Q44360884 | Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody |
| Q40647102 | Disseminated immune deposits in lupus erythematosus |
| Q41205167 | Does rheumatoid factor protect lupus patients from the development of nephritis? |
| Q69612574 | Editorial: Cytotoxic drugs and lupus nephritis |
| Q44112212 | Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study |
| Q45245883 | Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus |
| Q36237845 | Gender differences in systemic lupus erythematosus |
| Q41194741 | Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis |
| Q36078458 | Glomerulonephritis associated with sarcoidosis |
| Q35284617 | Glomerulonephritis in Children: Clinical and Morphologic Characteristics and Mechanisms of Glomerular Injury |
| Q69259475 | Histologic features that correlate with the prognosis of patients with lupus nephritis |
| Q30443641 | History of the renal section, New York University School of Medicine 1926-1986, New York University Medical Center |
| Q45177766 | Idiopathic membranous glomerulopathy preceding the emergence of systemic lupus erythematosus in two children |
| Q72294700 | IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies |
| Q39830587 | Immune complex nephropathy in mixed connective tissue disease |
| Q34517767 | Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease |
| Q69384192 | Immunologic events preceding clinical exacerbation of systemic lupus erythematosus |
| Q36076938 | Immunopathology of early and clinically silent lupus nephropathy |
| Q33483081 | Immunopharmacology of corticosteroids |
| Q36269226 | Immunosuppressive Therapy in Rheumatic Disease |
| Q40883177 | Immunosuppressive drug therapy in lupus nephritis |
| Q40652709 | Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic Epithelium |
| Q77357899 | Intraglomerular monocyte infiltration and immune deposits in diffuse lupus glomerulonephritis |
| Q35957799 | Laboratory diagnosis and monitoring of rheumatologic diseases |
| Q67444638 | Long-term azathioprine-corticosteroid therapy in lupus nephritis and idiopathic nephrotic syndrome |
| Q66912444 | Long-term maintenance therapy with azathioprine in systemic lupus erythematosus |
| Q67290871 | Lupus erythematosus |
| Q36716723 | Lupus nephritis and lupus band test. |
| Q69614704 | Lupus nephritis in childhood: cyclophosphamide--yes or no? |
| Q37201337 | Lupus nephritis: clinicopathological study of 162 cases in Thailand |
| Q40758583 | Lupus nephritis: lessons from the path lab. |
| Q35145310 | Lupus nephritis: response to azathioprine |
| Q36054868 | Membranous lupus nephritis |
| Q42823544 | Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study |
| Q44774950 | Nephritis in systemic lupus erythematosus |
| Q44840926 | Nephritis in systemic lupus erythematosus in children |
| Q70594857 | Nephrotic syndrome |
| Q58333215 | Nephrotic syndrome in mesangial proliferative lupus nephritis |
| Q33475874 | Occult lupus nephropathy: a correlated light, electron and immunofluorescent microscopic study |
| Q67337023 | On survivorship in the nephritis of systemic lupus erythematosus |
| Q41165180 | Outcome of silent lupus nephritis |
| Q67278720 | Pathogenesis of uremic pneumonitis (author's transl) |
| Q70302563 | Pathologic differentiation between lupus and nonlupus membranous glomerulopathy |
| Q36054832 | Pathology of lupus nephritis |
| Q77357903 | Persistent lupus activity in end-stage renal disease |
| Q46839690 | Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group |
| Q67982443 | Prognostic factors in diffuse proliferative lupus glomerulonephritis |
| Q33286668 | Prognostic factors in systemic lupus erythematosus |
| Q41331115 | Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis |
| Q48702125 | Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4 |
| Q70240417 | Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis |
| Q44641122 | Remission of refractory lupus nephritis with a protocol including rituximab |
| Q35531756 | Renal disease |
| Q44835673 | Renal histology and clinical course of systemic lupus erythematosus. A prospective study |
| Q33556732 | Rheumatoid factor in rheumatoid arthritis associated renal disease and in lupus nephritis |
| Q67560104 | Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group |
| Q71816963 | Serum and Urinary Fibrin/Fibrinogen Degradation Products in Glomerulonephritis |
| Q69633509 | Short-term prognosis of severe proliferative lupus nephritis |
| Q30731634 | Spatial arrangement of subepithelial deposits in lupus and nonlupus membranous nephropathy |
| Q93722902 | Sterility and cyclophosphamide |
| Q71974823 | Systemic lupus erythematosus in Saudi patients |
| Q33553002 | Systemic lupus erythematosus in childhood |
| Q33562068 | Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. |
| Q40001885 | The Immunologic Basis of Human Renal Disease |
| Q70237799 | The Long-Term Clinical Course of Systemic Lupus Erythematosus in End-Stage Renal Disease |
| Q88984435 | The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study |
| Q36314988 | The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions |
| Q39932900 | The Rheumatic Diseases in Adolescence |
| Q71079970 | The Treatment of Severe Glomerulopathies in Children Using High Dose Intravenous Methylprednisolone Pulses |
| Q39723922 | The chronic glomerulonephritides of childhood. Part I |
| Q67299666 | The distribution and character of glomerular deposits in systemic lupus erythematosus |
| Q53804961 | The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. |
| Q39941874 | The rheumatic diseases of childhood |
| Q43546465 | The significance of a positive cutaneous immunofluorescence test in systemic lupus erythematosus |
| Q36727769 | The significance of arterial hypertension at the onset of clinical lupus nephritis |
| Q39749422 | The treatment of lupus nephritis |
| Q36715090 | The treatment of lupus nephritis by methyl prednisolone pulse therapy |
| Q67592070 | The treatment of the nephritis of lupus erythematosus |
| Q67752623 | Treatment of Membranous Glomerulonephropathy |
| Q28372716 | Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression |
Search more.